膀胱癌に関する研究 - 術後再発予防についての検討 -

概要

論文の詳細を見る
In order to prevent postoperative recurrence of bladder cancer we have given Glucaron orally to 50 patients with bladder cancer in our clinic since 1971. This time, we compared the group of 30 cases given Glucaron with another group of 17 cases not given Glucaron. Both groups consisted of low stage and low grade tumors primarily treated by transurethral resection. 1) In one-year follow-up, the recurrence rate of Glucaron group was lower than the non-Glucaron group. However, in long-years follow-up the recurrence rate showed no difference. 2) The recurrence rate during the period of Glucaron administration was compared with that during the period without Glucaron in the same patients groups. Glucaron showed some effect of prophylaxis against recurrence. 3) Even in such a long-term administration of Glucaron, no side-effects were observed.
泌尿器科紀要刊行会の論文